Related Experiment Video
Updated: Jun 22, 2025
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Polymorphisms in the Dopaminergic Receptor D3 Gene Correlate with Disease Progression Rate in Relapsing-Remitting
Marco Ferrari1, Domizia Vecchio2,3, Sandra D'Alfonso3,4
1Center of Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.
Background:
Multiple sclerosis (MS) is a common chronic autoimmune disease of the central nervous system. In MS, disability progresses unpredictably. Dopamine (DA) is a modulator of immune functions, and compelling evidence supports its involvement in both pathogenesis and treatment of MS. Although single nucleotide polymorphisms (SNPs) in dopaminergic receptor (DR) genes have been extensively studied, their role in MS progression remains unexplored. Therefore, the aim of this explorative study is to investigate the potential association between functional SNPs in DR genes and MS progression.
Methods:
Caucasian patients with relapsing-remitting (RR) MS were enrolled, and disease progression assessed by the Multiple Sclerosis Severity Score (MSSS).
Results:
Out of the 59 RRMS patients enrolled, those with the G/G genotype for rs6280 and rs1800828 SNPs in DRD3 showed significantly higher MSSSs compared to those with ancestral and heterozygous genotypes.
Conclusions:
If confirmed in a larger prospective study, the reported findings could contribute to a better understanding of MS pathophysiological mechanisms, opening the way for the identification of marker(s) for assessing MS progression as well as novel therapeutic strategies. A personalized approach to MS management has the potential to improve the overall well-being of MS patients and alleviate the burden on their caregivers.
Insights
Specific gene variants in dopamine receptors are linked to faster disability progression in Multiple Sclerosis (MS). This finding may help predict MS worsening and guide personalized treatment strategies.
Area of Science:
- Neuroimmunology
- Genetics
- Neurology
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system, characterized by unpredictable disability progression.
- Dopamine (DA) plays a role in immune modulation, with implications for MS pathogenesis and treatment.
- The association between genetic variations in dopamine receptor (DR) genes and MS progression is largely unexplored.
Purpose of the Study:
- To investigate the potential link between functional single nucleotide polymorphisms (SNPs) in dopamine receptor genes and the progression of disability in Multiple Sclerosis patients.
Main Methods:
- Caucasian patients diagnosed with relapsing-remitting MS (RRMS) were recruited for the study.
- Disease progression was quantified using the Multiple Sclerosis Severity Score (MSSS).
Main Results:
- Patients with the G/G genotype for rs6280 and rs1800828 SNPs in the DRD3 gene exhibited significantly higher MSSS scores.
- This suggests a correlation between specific DRD3 genotypes and more severe MS progression compared to other genotypes.
Conclusions:
- The findings suggest that specific DRD3 gene variants may serve as potential markers for assessing MS progression.
- Further validation in larger prospective studies could pave the way for novel therapeutic strategies and personalized MS management.
- Identifying such markers could improve patient well-being and reduce caregiver burden.
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
01:28Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
01:15Parkinson's Disease: Overview